PYC Therapeutics Limited (ASX:PYC)
Australia · Delayed Price · Currency is AUD 2.250
-0.010 (-0.44%)
Aug 28, 2026, 4:10 PM AEST
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of 2.22 billion as of August 28, 2026. Its market cap has increased by 194.28% in one year.
Market Cap
2.22B
Enterprise Value
2.10B
Revenue
20.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.25
ChartMarket Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 28.04M to 2.22B, an increase of 7,825.70%. That is a compound annual growth rate of 22.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.22B | 130.26% |
| Dec 31, 2025 | 965.30M | 56.72% |
| Dec 31, 2024 | 615.92M | 50.00% |
| Dec 29, 2023 | 410.62M | 87.08% |
| Dec 30, 2022 | 219.48M | -48.89% |
| Dec 31, 2021 | 429.43M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.29B |
| Mesoblast | 3.13B |
| Neuren Pharmaceuticals | 2.66B |
| Clarity Pharmaceuticals | 936.43M |
| Racura Oncology | 441.16M |
| Clinuvel Pharmaceuticals | 427.12M |
| Starpharma Holdings | 341.09M |
| Tetratherix | 341.02M |